Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1105

Similar articles for PubMed (Select 15189108)

1.

Tardive dyskinesia rates with atypical antipsychotics in older adults.

Jeste DV.

J Clin Psychiatry. 2004;65 Suppl 9:21-4. Review.

PMID:
15189108
2.

Tardive dyskinesia in older patients.

Jeste DV.

J Clin Psychiatry. 2000;61 Suppl 4:27-32.

PMID:
10739328
3.

Conventional vs. newer antipsychotics in elderly patients.

Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J.

Am J Geriatr Psychiatry. 1999 Winter;7(1):70-6. Review.

PMID:
9919323
4.

Expected incidence of tardive dyskinesia associated with atypical antipsychotics.

Glazer WM.

J Clin Psychiatry. 2000;61 Suppl 4:21-6. Review.

PMID:
10739327
5.

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.

Peritogiannis V, Tsouli S.

J Psychopharmacol. 2010 Jul;24(7):1121-5. doi: 10.1177/0269881109103827. Epub 2009 Apr 24.

PMID:
19395427
6.
7.

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Correll CU, Leucht S, Kane JM.

Am J Psychiatry. 2004 Mar;161(3):414-25. Review.

PMID:
14992963
8.
9.

Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.

Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.

J Clin Psychiatry. 2003 Sep;64(9):1075-80.

PMID:
14628983
10.

Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.

Gourzis P, Polychronopoulos P, Papapetropoulos S, Assimakopoulos K, Argyriou AA, Beratis S.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):195-6.

PMID:
16062102
11.

Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.

Kane JM.

J Clin Psychiatry. 2004;65 Suppl 9:16-20. Review.

PMID:
15189107
12.

The treatment of tardive dyskinesia and tardive dystonia.

Simpson GM.

J Clin Psychiatry. 2000;61 Suppl 4:39-44. Review.

PMID:
10739330
13.

[Utility of quetiapine in tardive dyskinesia].

Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.

Actas Esp Psiquiatr. 2003 Nov-Dec;31(6):347-52. Review. Spanish.

PMID:
14639511
14.
15.

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.

Nelson MW, Reynolds RR, Kelly DL, Conley RR.

Clin Neuropharmacol. 2003 Nov-Dec;26(6):297-8.

PMID:
14646608
16.

Tardive dyskinesia with quetiapine.

Ghelber D, Belmaker RH.

Am J Psychiatry. 1999 May;156(5):796-7. No abstract available.

PMID:
10327920
17.

Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.

Glazer WM.

J Clin Psychiatry. 2000;61 Suppl 3:16-21. Review.

PMID:
10724129
18.

Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.

Duggal HS, Mendhekar DN.

Am J Psychiatry. 2006 Aug;163(8):1449-50. No abstract available.

PMID:
16877664
19.

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.

Tollefson GD, Beasley CM Jr, Tamura RN, Tran PV, Potvin JH.

Am J Psychiatry. 1997 Sep;154(9):1248-54.

PMID:
9286184
20.

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R, Annable L.

Can J Psychiatry. 2005 Oct;50(11):703-14. Review.

PMID:
16363464
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk